Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy
ALAMEDA, Calif.– Infinimmune, a biotechnology company pioneering antibody discovery and design, today announced the appointment of Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy. In this role, Dr. Slavin will…